Cumulative aducanumab safety data from prime: A randomized, double-blind, placebocontrolled, phase 1b study

Authors
Category Primary study
ConferenceJournal of Prevention of Alzheimer's Disease
Year 2018
This article has no abstract
Epistemonikos ID: 5288314ef78733d2f6060143f38c0a8c62ed7e45
First added on: Apr 30, 2026